A Phase 1 Study of AP02 (Nintedanib Solution for Inhalation) Delivered via the PARI eFlow&#174; Nebulizer System to Evaluate the Safety, Tolerability, and Pharmacokinetics of AP02 in Healthy Volunteers (AP02-002)

nintedanib inhaled (AP02) - Avalyn Pharma

Jan 31, 2025